Evaluation of Tumor Response

Tumor response evaluation is of great significance in the clinical treatment of tumors. Medical imaging technology has always been a common technical means in tumor diagnosis, prognosis and response evaluation, and the research of imaging biomarkers also has huge development potential in tumor response evaluation. As an expert in the field of biomarkers, Creative BioMart Biomarker provides a variety of outsourcing services related to imaging biomarkers, including evaluation of tumor response. In addition, we also provide imaging biomarker detection services related to disease risk evaluation, disease staging and prognosis evaluation.

Introduction

Tumors are a type of disease that is common worldwide and has a high mortality rate. The general situation of tumors is more complicated, even patients with the same tumor type, tumor stage, and clinical manifestations may have different treatment responses to the same treatment. In addition, with the development of cancer knowledge and biological sciences, new methods for tumor treatment have emerged. Therefore, it is necessary to evaluate tumor response accurately and objectively. Response evaluation criteria in solid tumors (RECIST) is a standard commonly used by researchers all over the world to evaluate the response of solid tumors. In this standard, tumor response is considered to be the expected end point of early clinical trials, and it is also a guide for clinicians and patients or subjects to decide whether to continue current treatment. Tumor response evaluation standards include evaluation of target lesions, nontarget lesions, best overall response, etc. Changes in tumor size and function can predict disease progression and survival time, and imaging biomarkers can be used as an alternative clinical endpoint for tumor response evaluation. Imaging biomarkers have the advantages of unbiased, reproducible, minimally invasive and comprehensive evaluation. At the same time, imaging biomarkers can quantify irregular shapes and invasive or diffuse tumors. The application of imaging biomarkers in tumor response evaluation can analyze and evaluate tumor characteristics such as tumor size through medical images, assist in the monitoring of tumor progression and evaluation of tumor response. Tumor imaging biomarkers related to tumor response evaluation include tumor diameter, area, volume, etc. With the development of imaging technology, such as magnetic resonance imaging (MRI) and computerized tomography (CT), imaging biomarkers have huge development potential and research space in the field of tumor response assessment.

Evaluation of Tumor Response
Figure 1. Tumor imaging biomarker. (Cai, et al. 2018)

Our Imaging Biomarker Detection Services Related to Evaluation of Tumor Response:

  • Tumor Metabolism-related Imaging Biomarker Detection Service
  • Tumor Oxygenation Status-related Imaging Biomarker Detection Service
  • Neovascularization-related Imaging Biomarker Detection Service
  • Abnormal Value Added-related Imaging Biomarker Detection Service
  • Tumor Apoptosis-related Imaging Biomarker Detection Service
  • Specific Molecular Probe-related Imaging Biomarker Detection Service

Our Advantages

  • Multiple imaging biomarkers detection technology platforms
  • Ensure high accuracy and precision imaging biomarkers detection service
  • Provide quantitative imaging biomarkers detection service
  • Provide detailed professional analysis report
  • Customized service scheme according to the specific needs
  • Shorter service cycle and more competitive prices
  • Experienced technical team

Workflow of Imaging Biomarker Detection at Creative BioMart Biomarker

Evaluation of Tumor Response

At Creative BioMart Biomarker, we provide customers with high-quality imaging biomarker detection services related to tumor response evaluation. Customers can discuss with our expert team based on specific research needs or research objects, and we will work out the appropriate experimental plan as soon as possible. Our technical team has extensive experience in the field of imaging biomarkers, and has been strictly controlling every process in the imaging biomarker detection service to ensure that customers are provided with accurate test results. If you are seeking related services, Creative BioMart Biomarker may be your ideal choice, please feel free to contact us for more information.

References:

  1. Therasse, P.; et al. New guidelines to evaluate the response to treatment in solid tumors. JNCI Journal of the National Cancer Institute. 2000, 92(3): 205-216.
  2. Cai, W. L.; Hong, G. B. Quantitative image analysis for evaluation of tumor response in clinical oncology. Chronic Diseases and Translational Medicine. 2018, 4(1): 18-28.
  3. Rezai, P.; et al. A radiologist’s guide to treatment response criteria in oncologic imaging: anatomic imaging biomarkers. American Journal of Roentgenology. 2013, 201(2): 237-245.

Menu

Contact Us

Subscribe

Enter your email here to subscribe